Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Eugene, Oregon Clinical Trials

A listing of Eugene, Oregon clinical trials actively recruiting patient volunteers.

RESULTS

Found (3) clinical trials

Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of BAY 1251152 in patients with solid tumors and aggressive non-hodgkin's lymphoma (NHL).

Phase

1.14 miles

Learn More »

A Study of GDC-0199 (ABT-199) in Combination With Obinutuzumab in Patients With Chronic Lymphocytic Leukemia

This multi-center, open-label, dose-finding study will evaluate the safety and pharmacokinetics of GDC-0199 (ABT-199) administered in combination with obinutuzumab to patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia. The anticipated time on study treatment is 6 months. !@#$%^&*()_+-=,."'\|`~

Phase

3.6 miles

Learn More »

Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome

A dose-escalation and dose-expansion study of MEDI4736 (a monoclonal antibody that targets programmed cell death-1 ligand 1 [PD-L1]) to evaluate the safety, tolerability, PK, IM, and antitumor activity of MEDI4736 as monotherapy or in combination with Tremelimumab with or without Azacitidine in adult patients with myelodysplastic syndrome.

Phase

3.6 miles

Learn More »